We are live on ! Find out more
WST icon

West Pharmaceutical

838 hedge funds and large institutions have $25.3B invested in West Pharmaceutical in 2026 Q2 according to their latest regulatory filings, with 145 funds opening new positions, 307 increasing their positions, 264 reducing their positions, and 61 closing their positions.

New
Increased
Maintained
Reduced
Closed

138% more first-time investments, than exits

New positions opened: 145 | Existing positions closed: 61

76% more call options, than puts

Call options by funds: $81.3M | Put options by funds: $46.1M

50% more funds holding in top 10

Funds holding in top 10: 6 → 9 (+3)

16% more repeat investments, than reductions

Existing positions increased: 307 | Existing positions reduced: 264

11% more funds holding

Funds holding: 758 → 838 (+80)

1.08% more ownership

Funds ownership: 98.69% → 99.77% (+1.1%)

18% less capital inflows, than outflows

Capital inflows: $2.07B | Capital outflows: $2.51B

Holders
838
Holders Change
+80
Holders Change %
+10.55%
% of All Funds
9.98%
Holding in Top 10
9
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+50%
% of All Funds
0.11%
New
145
Increased
307
Reduced
264
Closed
61
Calls
$81.3​M
Puts
$46.1​M
Net Calls
+$35.2​M
Net Calls Change
+$101​M

WST Hedge Fund Activity: Q2 2026 in Review

838 of the 8,401 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q2 2026, worth a combined $25.3B — up 42% from $17.8B a quarter earlier.

Buyers outnumbered sellers: 145 funds opened new WST positions and 61 closed out — a net gain of 84 holders — while 307 added to existing stakes and 264 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $711M. The largest seller was APG Asset Management, cutting an estimated $216M.

  • 838 institutional investors held West Pharmaceutical (WST) as of Q2 2026, up from 758 in Q1 2026.
  • Funds reported $25.3B of West Pharmaceutical stock for Q2 2026, up 42% quarter-over-quarter.
  • 145 funds opened new West Pharmaceutical positions in Q2 2026 and 61 closed out, a net change of +84 holders.
  • The largest West Pharmaceutical buyer in Q2 2026 was Fidelity Investments, an estimated $711M added.
  • The largest West Pharmaceutical seller in Q2 2026 was APG Asset Management, an estimated $216M sold.

Based on aggregated 13F filings for Q2 2026.